Invention Application
US20100190822A1 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
失效
药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
- Patent Title: Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
- Patent Title (中): 药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
-
Application No.: US12727558Application Date: 2010-03-19
-
Publication No.: US20100190822A1Publication Date: 2010-07-29
- Inventor: David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- Applicant: David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- Applicant Address: US IL Abbott Park
- Assignee: ABBOTT LABORATORIES
- Current Assignee: ABBOTT LABORATORIES
- Current Assignee Address: US IL Abbott Park
- Main IPC: A61K31/4725
- IPC: A61K31/4725 ; C07D207/16 ; A61K31/40 ; A61P3/10 ; A61P3/04 ; A61P3/08 ; C07D401/08 ; C07D401/14 ; A61K31/4545 ; C07D401/12 ; A61K31/454 ; A61K31/4439 ; C07D403/08 ; A61K31/4025
Abstract:
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
Public/Granted literature
- US08119664B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) Public/Granted day:2012-02-21
Information query
IPC分类:
